| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/20/2013 | EP2559439A1 Pharmaceutical preparation for treating benign prostatic hyperplasia |
| 02/20/2013 | EP2558579A2 Capping-prone rna polymerase enzymes and their applications |
| 02/20/2013 | EP2558491A1 Fibronectin based scaffold domain proteins that bind pcsk9 |
| 02/20/2013 | EP2558489A1 Robo1-fc fusion protein and use thereof for treating tumours |
| 02/20/2013 | EP2558488A1 Banana lectins and uses thereof |
| 02/20/2013 | EP2558123A2 Methods and compositions for inhibition of treg cells |
| 02/20/2013 | EP2558122A1 Combination treatment with vegf-c antagonists |
| 02/20/2013 | EP2558115A2 Methods for treating metabolic disorders using fgf |
| 02/20/2013 | EP2558114A2 Cancer methods |
| 02/20/2013 | EP2558113A2 Serca2 therapeutic compositions and methods of use |
| 02/20/2013 | EP2558112A1 Compositions and methods for treating copd exacerbation |
| 02/20/2013 | EP2558111A1 Methods and related kits for treating and regenerating tooth pulp and periapical tissues in a mammal |
| 02/20/2013 | EP2558110A1 Extract and peptides derived from oryza sativa japonica group and uses thereof |
| 02/20/2013 | CN102939303A Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 02/20/2013 | CN102939301A Peptide compounds that can be used as antibacterial agents |
| 02/20/2013 | CN102939300A Preparation of crystalline ezatiostat hydrochloride ansolvate form d |
| 02/20/2013 | CN102939284A Agent for treating hcv infection |
| 02/20/2013 | CN102939110A Selective modification of proteins |
| 02/20/2013 | CN102939108A Conjugated blood coagulation factor viii |
| 02/20/2013 | CN102939099A Treating allergy with detoxified e. coli heat-labile enterotoxin |
| 02/20/2013 | CN102939097A A novel synergistic pharmaceutical composition for topical applications |
| 02/20/2013 | CN102939096A Vaccines for use in the prophylaxis and treatment of influenza virus disease |
| 02/20/2013 | CN102939095A Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterials |
| 02/20/2013 | CN102936288A Erythropoietin mimetic peptide fusion protein and mutant |
| 02/20/2013 | CN102936282A Gall-stone removing compound and application thereof |
| 02/20/2013 | CN102936281A RTRAIL(recombinant TNF(tumor necrosis factor) related apoptosis-inducing ligand) mutant and monomethyl auristatin E(MMAE) conjugate thereof |
| 02/20/2013 | CN102936277A Human blood vessel endothelial growth factor antigen epitope and epitope vaccine thereof |
| 02/20/2013 | CN102935230A Use of RNAi inhibiting PARP activtiy for the manufacture of a medicament for the treatment of cancer |
| 02/20/2013 | CN102935225A Sterilization agent for sea crab culture and application method thereof |
| 02/20/2013 | CN102935224A Medicinal extract ointment for treating skin scald |
| 02/20/2013 | CN102935223A Application of polypeptide GC25 in preparing anti-infective drug |
| 02/20/2013 | CN102935222A Application of ferric iron ferriporphyrin compound in preparation of anti-type-2 diabetes drug |
| 02/20/2013 | CN102935221A Anti-aging tablet |
| 02/20/2013 | CN102309758B Medicinal composition for treating diseases caused by enterovirus infections |
| 02/20/2013 | CN102258481B Method for preparing self-assembled medicine-carried microspheres by combining high-voltage electrostatic liquid droplet method and layer-by-layer self-assembly method |
| 02/20/2013 | CN102175682B Bioactivity detection method and application of recombined humanized neuroglobin |
| 02/20/2013 | CN102161656B Aspartic acid-specific caspase inhibitors and uses thereof |
| 02/20/2013 | CN102008715B Antitumor MA-TNF alpha medicine composition and application thereof |
| 02/20/2013 | CN102008710B Lisinopril-containing compound preparation for treating hypertension |
| 02/20/2013 | CN102008708B Ramipril-contained compound preparation for treating hypertension |
| 02/20/2013 | CN101849675B Dietary supplements containing natural ingredients |
| 02/20/2013 | CN101724019B Thymopeptide-5 active esters, medicinal composition containing same and application thereof |
| 02/20/2013 | CN101693106B Application of metallothionein on preparing medicines for treating diskal hernia and hyperosteogeny |
| 02/20/2013 | CN101678077B Novel antiphlogistic-analgesic agent |
| 02/20/2013 | CN101554386B Medicine composition for curing hepatic disease and preparation method thereof |
| 02/19/2013 | USRE44022 Cyclic peptides, method for preparing and use as angiogenesis inhibitors or activators |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8378072 solid phase synthesis of directed epitope peptide mixtures useful in the modulation of unwanted immune responses, such process defined by a set of rules regarding the identity and the frequency of occurrence of amino acids that substitute a base or native amino acid of a known epitope. |
| 02/19/2013 | US8378071 Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| 02/19/2013 | US8378070 Peptides for the regulation of neurotransmitter sequestration and release |
| 02/19/2013 | US8378067 Treatment for obesity |
| 02/19/2013 | US8378065 PMMA binding peptides |
| 02/19/2013 | US8378064 Hydrophilic polymers as medical lubricants and gels |
| 02/19/2013 | US8377912 Preparation for the prevention and/or treatment of vascular disorders |
| 02/19/2013 | US8377903 Cladribine regimen for treating multiple sclerosis |
| 02/19/2013 | US8377897 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/19/2013 | US8377891 Process for synthesis of cyclic octapeptide |
| 02/19/2013 | US8377890 Hair treatment agents having low-dose oligopeptides |
| 02/19/2013 | US8377889 Adiponectin receptor fragments and methods of use |
| 02/19/2013 | US8377887 Methods of reducing hypoxic stress in a mammal by administering soluble P-selectin |
| 02/19/2013 | US8377886 Use of gamma secretase inhibitors and notch pathway inhibitors for treatment and prevention of renal disease |
| 02/19/2013 | US8377885 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| 02/19/2013 | US8377884 Variants of C-type natriuretic peptides |
| 02/19/2013 | US8377883 Peptide for anti-angiogenesis and use thereof |
| 02/19/2013 | US8377882 Stabilization of interleukin 6 in serum based solutions |
| 02/19/2013 | US8377881 Compositions and methods for reducing scar formation in wound healing |
| 02/19/2013 | US8377880 Therapeutic agents for reducing parathyroid hormone levels |
| 02/19/2013 | US8377879 Follicle stimulating hormone superagonists |
| 02/19/2013 | US8377878 Therapies for chronic renal failure |
| 02/19/2013 | US8377877 Composition and method for reducing post-prandial blood glucose |
| 02/19/2013 | US8377876 Pediatric amino acid solution for parenteral nutrition |
| 02/19/2013 | US8377875 Therapeutics based on tau/microtubule dynamics |
| 02/19/2013 | US8377874 HCV NS3 protease inhibitors |
| 02/19/2013 | US8377873 HCV NS3 protease inhibitors |
| 02/19/2013 | US8377872 Cyclic P3 tripeptide hepatitis C serine protease inhibitors |
| 02/19/2013 | US8377871 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 02/19/2013 | US8377870 Antimicrobial aqueous solution and its preparation method |
| 02/19/2013 | US8377869 Method of preventing adverse effects by GLP-1 |
| 02/19/2013 | US8377868 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 02/19/2013 | US8377867 Use of epinecidin-1 peptides and anti-lipopolysaccharide factor peptides for treating microbial infection |
| 02/19/2013 | US8377866 Antimicrobial protein derived from Podoviridae bacteriophage specific to Staphylococcus aureus |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | US8377864 Fibrin gel for controlled release of PDGF and uses thereof |
| 02/19/2013 | US8377863 Peptide pharmaceutical for oral delivery |
| 02/19/2013 | US8377690 Cells and methods for producing blocking antibodies to human RANKL |
| 02/19/2013 | US8377654 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 02/19/2013 | US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders |
| 02/19/2013 | US8377477 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
| 02/19/2013 | US8377455 Biosurfactant composition produced by a new Bacillus licheniforms strain, uses and products thereof |
| 02/19/2013 | US8377452 Use of a botulinum neurotoxin to alleviate various disorders |
| 02/19/2013 | US8377447 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells |
| 02/19/2013 | US8377438 Methods of antagonizing signal transduction in spinal cord cells |
| 02/19/2013 | US8377434 Cosmetic composition for exfoliating skin keratin |
| 02/19/2013 | US8377420 Injectable void filler for soft tissue augmentation |
| 02/19/2013 | US8375947 Introducing aerosol into a ventilator |
| 02/19/2013 | DE202013000748U1 Sprühbare flüssige Zubereitung zur insbesondere nasalen Anwendung mit erhöhter lokaler Verweilzeit Sprayable liquid formulation for nasal application in particular with increased local residence |
| 02/19/2013 | CA2560981C Polymer-based sustained release device |
| 02/19/2013 | CA2560874C Poly (lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar |
| 02/19/2013 | CA2551525C Pharmaceutical composition for thrombin peptide derivatives |
| 02/19/2013 | CA2550013C Bactericide against streptococcus mutans and streptococcus sobrinus |